Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats
Acknowledgments The authors express their thanks to Drs Eckhardt Ferdinandi and Claude Larose (formerly of Theratechnologies Inc.) for providing the GLP-1 receptors agonists labelled above as G001 and G002, to Olga Plaskon, Estera Karolczyk, Kasia Zajkowska and Gurpal Bansal for technical assistance, and to Professor Huw Jones, Middlesex University for help with statistical analyses
As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026
Maintaining high liver glutathione is central to healthy detox capacity
Warm Lemon Water Simple, refreshing, and surprisingly effective
Medical Device Clinical Trials Market Key Takeaways North America dominates the global market by generating the largest share of 44% in 2025